Clinical Trial Update: Efficacy and Safety of Narlaprevir Used in Combination With Ritonavir in Treatment-Naïve and Failed Prior Treatment With Pegylated Interferon/Ribavirin Patients With Chronic Hepatitis C Genotype 1 (PIONEER - Study) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the efficacy and safety of narlaprevir boosted with ritonavir in treatment-naïve and pegylated interferon/ribavirin–failure patients wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Narlaprevir (narlaprevir)
• Norvir (ritonavir)

Snippet

Sponsor: R-Pharm | Conditions: Hepatitis C | Phase 3 | Status: COMPLETED